Research article Open Access
Like 0


Human T-lymphotropic virus (HTLV) infection has been under enhanced surveillance in England and Wales since 2002, however, little is known about testing patterns. Using data from two surveillance systems held at Public Health England, we described HTLV antibody testing patterns between 2008 and 2013 and the demographic and clinical characteristics of persons diagnosed with HTLV in England and Wales between 2004 and 2013. An increase in HTLV testing was observed in England between 2008 and 2013 (3,581 to 7,130). Most tests (82%; 7,597/9,302) occurred within secondary care, 0.5% (48/9,302) of persons were reactive for HTLV antibodies and 0.3% (27/9,302) were confirmed positive. Increasing age and female sex were predictors of a reactive HTLV screen and confirmed diagnosis. Testing in primary care including sexual health and antenatal services was infrequent. Between 2004 and 2013, 858 people were diagnosed with HTLV, most of whom were female (65%; 549/851), of black Caribbean ethnicity (60%), not born in the United Kingdom (72%; 369/514) and asymptomatic at diagnosis (45%; 267/595). Despite increased testing, the epidemiology and clinical features of those diagnosed with HTLV have remained consistent. Apart from donor screening, testing for HTLV infection remains uncommon, except to diagnose associated disease.


Article metrics loading...

Loading full text...

Full text loading...



  1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77(12):7415-9.  https://doi.org/10.1073/pnas.77.12.7415  PMID: 6261256 
  2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982;218(4572):571-3.  https://doi.org/10.1126/science.6981847  PMID: 6981847 
  3. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.  https://doi.org/10.3389/fmicb.2012.00388  PMID: 23162541 
  4. Bangham CR. HTLV-1 infections. J Clin Pathol. 2000;53(8):581-6.  https://doi.org/10.1136/jcp.53.8.581  PMID: 11002759 
  5. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Volume 67: Human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon: IARC;1996. Available from: http://monographs.iarc.fr/ENG/Monographs/vol67/mono67.pdf
  6. Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology. 2003;61(11):1588-94.  https://doi.org/10.1212/01.WNL.0000096011.92542.DA  PMID: 14663047 
  7. Fujino T, Nagata Y. HTLV-I transmission from mother to child. J Reprod Immunol. 2000;47(2):197-206.  https://doi.org/10.1016/S0165-0378(00)00054-1  PMID: 10924751 
  8. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis. 1993;167(1):57-65.  https://doi.org/10.1093/infdis/167.1.57  PMID: 8418183 
  9. van Hoeven LR, Janssen MP, Rautmann G, European Committee on Blood Transfusion (EDQM). The collection, testing and use of blood and blood components in Europe. 2013 report. Brussels: European Directorate for the Quality of Medicines and HealthCare of the Council of Europe; 2016. Available from:https://www.edqm.eu/sites/default/files/the_collection_testing_and_use_of_blood_and_blood_components_in_europe_2013.pdf
  10. Simms I, Tosswill JH, Noone A, Morgan D. Surveillance of HTLV infection in England and Wales: 1986-1992. Commun Dis Rep CDR Rev. 1994;4(6):R65-9. PMID: 7519514 
  11. Payne LJ, Tosswill JH, Taylor GP, Zuckerman M, Simms I. In the shadow of HIV-HTLV infection in England and Wales, 1987-2001. Commun Dis Public Health. 2004;7(3):200-6. PMID: 15481213 
  12. Tosswill JH, Taylor GP, Tedder RS, Mortimer PP. HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. BMJ. 2000;320(7235):611-2.  https://doi.org/10.1136/bmj.320.7235.611  PMID: 10698878 
  13. Ades AE, Parker S, Walker J, Edginton M, Taylor GP, Weber JN. Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study. BMJ. 2000;320(7248):1497-501.  https://doi.org/10.1136/bmj.320.7248.1497  PMID: 10834889 
  14. Public Health England. Annual report from the sentinel surveillance study of blood borne virus testing in England: data for January to December 2015. Health Protection Report. 10(24);2016. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/540332/hpr2416_bbvs.pdf
  15. Brant LJ, Hurrelle M, Balogun MA, Klapper P, Ahmad F, Boxall E, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiol Infect. 2007;135(3):417-26.  https://doi.org/10.1017/S0950268806006832  PMID: 16836798 
  16. Dougan S, Smith A, Tosswill JC, Davison K, Zuckerman M, Taylor GP. New diagnoses of HTLV infection in England and Wales: 2002-2004. Euro Surveill. 2005;10(10):232-5. PMID: 16282645 
  17. Office for National Statistics (ONS). 2013 Birth summary tables - England and Wales. London: ONS. [Accessed: 5 Jun 2016]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/datasets/birthsummarytables
  18. Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano VSpanish HIV-2/HTLV Study Group. The burden of neglected HIV-2 and HTLV-1 infections in Spain. AIDS Rev. 2015;17(4):212-9. PMID: 26616845 
  19. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989;111(7):555-60.  https://doi.org/10.7326/0003-4819-111-7-555  PMID: 2789009 
  20. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis. 1986;154(5):851-7.  https://doi.org/10.1093/infdis/154.5.851  PMID: 2877031 
  21. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989;111(7):555-60.  https://doi.org/10.7326/0003-4819-111-7-555  PMID: 2789009 
  22. Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;1;12(2):193-201.
  23. Public Health England (PHE). Supplementary data tables and figures 2014. NHS Blood and Transplant/Public Health England Epidemiology Unit. London: PHE; 2015.Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/474175/NHSBT_PHE_Annual_Review_Supplementary_Data_2014.pdf
  24. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147-52. PMID: 10718692 
  25. Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences of symptom reporting and medical health care utilization in the German population. Eur J Epidemiol. 2000;16(6):511-8.  https://doi.org/10.1023/A:1007629920752  PMID: 11049093 
  26. Green CA, Pope CR. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med. 1999;48(10):1363-72.  https://doi.org/10.1016/S0277-9536(98)00440-7  PMID: 10369437 
  27. Lima MA, Bica RB, Araújo AQ. Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry. 2005;76(2):294-6.  https://doi.org/10.1136/jnnp.2004.035709  PMID: 15654060 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error